πŸ‡΅πŸ‡ͺ Country Profile

Peru

Fast-growing pharmaceutical trade with Peru

πŸ‡΅πŸ‡ͺ $110M
All data from DGCIS India export records (fiscal year, April–March).
$110M
Scale
Peru's patients receive $110M in Indian pharmaceutical products annually β€” almost entirely finished medicines ready for dispensing.
78%
Medicine
Overwhelmingly finished medicines β€” drug formulations account for 78% of shipments.
3.1Γ—
Trajectory
One of the faster-growing relationships β€” India's pharmaceutical supply to Peru has expanded 3.1Γ— over the decade.
Context
Part of India's pharmaceutical supply network across Americas.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in Peru β€” building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix — FY 2025–26 DGCIS
Medicines $85.4M (78.0%) Medicine Ingredients $9.4M (8.6%) Vaccines $8.2M (7.5%) Surgical & Hospital Supplies $6.2M (5.6%) Traditional & Herbal $0.37M (0.3%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in Peru Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Peru: $15.9M across 36 filings (2013-2021).